Galmed Pharmaceuticals annual debt-to-assets ratio
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Galmed Pharmaceuticals Debt-to-Assets Ratio Growth & History (GLMD)
Galmed Pharmaceuticals's debt-to-assets ratio was 0.00 for fiscal 2025.
View full Galmed Pharmaceuticals company overviewGalmed Pharmaceuticals annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.00 | 0.00 | — |
| 2024 | 2024-12-31 | 0.00 | −0.00 | — |
| 2023 | 2023-12-31 | 0.00 | −0.01 | −81.10% |
| 2022 | 2022-12-31 | 0.01 | 0.00 | +9.75% |
| 2021 | 2021-12-31 | 0.01 | 0.00 | +48.56% |
| 2020 | 2020-12-31 | 0.01 | 0.00 | +15.55% |
| 2019 | 2019-12-31 | 0.01 | 0.01 | — |
| 2018 | 2018-12-31 | 0.00 | 0.00 | — |
| 2017 | 2017-12-31 | 0.00 | −0.05 | — |
| 2016 | 2016-12-31 | 0.05 | 0.04 | +563.31% |
| 2015 | 2015-12-31 | 0.01 | −0.00 | −39.95% |
| 2014 | 2014-12-31 | 0.01 | −2.57 | −99.53% |
| 2013 | 2013-12-31 | 2.58 | — | — |
Galmed Pharmaceuticals quarterly debt-to-assets ratio
Q4.13
Q4.14
Q4.15
Q2.16
Q4.16
Q2.17
Q4.17
Q2.18
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q4.23
Q4.24
Q2.25
Q3.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.01 | 0.01 | — |
| Q4 2025 | 2025-12-31 | 0.00 | 0.00 | — |
| Q3 2025 | 2025-09-30 | 0.00 | — | — |
| Q2 2025 | 2025-06-30 | 0.00 | — | — |
| Q4 2024 | 2024-12-31 | 0.00 | −0.00 | — |
| Q4 2023 | 2023-12-31 | 0.00 | −0.01 | −81.10% |
| Q4 2022 | 2022-12-31 | 0.01 | 0.00 | +9.75% |
| Q2 2022 | 2022-06-30 | 0.01 | −0.00 | −6.47% |
| Q4 2021 | 2021-12-31 | 0.01 | 0.00 | +48.56% |
| Q2 2021 | 2021-06-30 | 0.01 | 0.00 | +57.02% |
| Q4 2020 | 2020-12-31 | 0.01 | 0.00 | +15.55% |
| Q2 2020 | 2020-06-30 | 0.00 | −0.00 | −25.47% |
| Q4 2019 | 2019-12-31 | 0.01 | 0.01 | — |
| Q2 2019 | 2019-06-30 | 0.01 | 0.01 | — |
| Q4 2018 | 2018-12-31 | 0.00 | 0.00 | — |
| Q2 2018 | 2018-06-30 | 0.00 | −0.01 | — |
| Q4 2017 | 2017-12-31 | 0.00 | −0.05 | — |
| Q2 2017 | 2017-06-30 | 0.01 | 0.00 | +21.30% |
| Q4 2016 | 2016-12-31 | 0.05 | 0.04 | +563.31% |
| Q2 2016 | 2016-06-30 | 0.01 | — | — |
| Q4 2015 | 2015-12-31 | 0.01 | −0.00 | −39.95% |
| Q4 2014 | 2014-12-31 | 0.01 | −2.57 | −99.53% |
| Q4 2013 | 2013-12-31 | 2.58 | — | — |
Galmed Pharmaceuticals debt-to-assets ratio trends
Over the last five fiscal years, Galmed Pharmaceuticals's debt-to-assets ratio decreased from 0.01 to 0.00, a change of −0.01. The latest reported quarter, Q2 2026, shows 0.01.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Galmed Pharmaceuticals source filings ↗